Ethical Considerations in the Framing of the Cognitive Enhancement Debate
- 831 Downloads
Over the past few years the use of stimulants such as methylphenidate and modafinil among the student population has attracted considerable debate in the pages of bioethics journals. Under the rubric of cognitive enhancement, bioethicists have discussed this use of stimulants—along with future technologies of enhancement—and have launched a sometimes forceful debate of such practices. In the following paper, it is argued that even if we focus solely upon current practices, the term cognitive enhancement encompasses a wide range of ethical considerations that can usefully be addressed without the need for speculation. In taking this position it is suggested that we divide cognitive enhancement into a series of empirically-constructed frameworks—medical risks and benefits, self-medication and under-prescription, prescription drug abuse and over-medication, and finally, the intention to cognitively enhance. These are not mutually exclusive frameworks, but provide a way in which to identify the scope of the issue at hand and particular ethical and medical questions that may be relevant to enhancement. By a process of elimination it is suggested that we can indeed talk of cognitive enhancement as an observable set of practices. However, in doing so we should be aware of how academic commentaries and discussion may be seen as both capturing reality and reifying cognitive enhancement as an entity.
KeywordsBioethics Cognitive enhancement Framing Stimulants
The author would like to thank Professor Wayne Hall of the Addiction Neuroethics unit University of Queensland for comments on an earlier draft of this paper.
Research funded by Canadian Institutes of Health Research, NNF 80045, States of Mind: Emerging Issues in Neuroethics
Conflict of Interest
- 4.Chatterjee, A. 2006. The promise and predicament of cosmetic neurology. Journal of Medical Ethics 32: 110e13.Google Scholar
- 5.Farah, Martha J., Judy Illes, Robert Cook-Deegan, Howard Gardner, Eric Kandel, Patricia King, Eric Parens, Barbara Sahakian, and Paul Root Wolpe. 2004. Neurocognitive enhancement: What can we do and what should we do? Nature Reviews: Neuroscience: 421–5.Google Scholar
- 10.Banjo, O.C., R. Nadler, and P.B. Reiner. 2010. Physician attitudes towards pharmacological cognitive enhancement: Safety concerns are paramount. PLoS One 5(12). doi: 10.1371/journal.pone.0014322.
- 14.BMA. Boosting your Brainpower: Ethical Aspects of Cognitive Enhancement. 2007. available from http://www.bma.org.uk/images/Boosting_brainpower_tcm41-147266.pdf, [accessed 21 February 2011].
- 16.Barrett, S.P., C. Darredeau, L.E. Bordy, and R.O. Pihl. 2005. Characteristics of methylphenidate misuse in a university student sample. Canadian Journal of Psychiatry 50(8): 457–461.Google Scholar
- 21.Johnston, L. D., O’Malley, P. M., Bachman, J. G., and Schulenberg, J. E. 2010. Monitoring the Future national survey results on drug use, 1975–2009: Volume II, College students and adults ages 19–50 (NIH Publication No. 10–7585). Bethesda, MD:National Institute on Drug Abuse. Table 2–2.Google Scholar
- 23.Johnston, L. D., O’Malley, P. M., Bachman, J. G., and Schulenberg, J. E. 2010. Monitoring the Future national survey results on drug use, 1975–2009: Volume II, College students and adults ages 19–50 (NIH Publication No. 10–7585). Bethesda, MD:National Institute on Drug Abuse. Table 2–2 p.47.Google Scholar
- 28.Kooij, J.J.S., H. Burger, A.M. Boonstra, P.D. Van Der Linden, L.E. Kalma, and J.K. Buitelaar. 2004. Efficacy and Safety Of Methylphenidate in 45 Adults With attention-deficit/hyperactivity disorder. A randomized placebo-controlled double-blind cross-over trial. Psychological Medicine 34(6): 973–982.CrossRefGoogle Scholar
- 30.Schermer, M., I. Bolt, R. de Jong, and B. Olivier. 2009. The future of psychopharmacological enhancements: Expectations and policies. Neuroethics 2 (2): 75–87Google Scholar
- 32.Partnership Attitude Tracking Study (Teens) DEA. 2009. Available from: www.getsmartaboutdrugs.com/identify/partnership_attitudetracking_study_teens.html. [Accessed 8 June, 2011].
- 34.Wilens, T.E., L.A. Adler, J. Adams, S. Sgambati, J. Rotrosen, R. Sawtelle, L. Utzinger, and S. Fusillo. 2008. Misuse and diversion of stimulants prescribed for ADHD: A systematic review of the literature. Journal of the American Academy of Child & Adolescent Psychiatry 47(1): 21–31.CrossRefGoogle Scholar
- 35.DSM-IV-TR® Diagnostic and Statistical Manual of Mental Disorders. Available at: http://www.psychiatryonline.com/content.aspx?aID=7721&searchStr=attention-deficit%2fhyperactivity+disorder [accessed 12 June, 20111]
- 36.Kessler, Ronald C., Lenard Adler, Russell Barkley, Joseph Biederman, C.Keith Conners, Olga Demler, and Stephen V. Faraone. 2006. The prevalence and correlates of adult ADHD in the united states: Results from the national comorbidity survey replication. American Journal of Psychiatry 163: 716–723.CrossRefGoogle Scholar
- 40.INCB. 2009. International Narcotics Control Board Report. Available: http://www.incb.org/pdf/annual-report/2009/en/AR_09_English.pdf (accessed Jan 20, 2011).
- 49.Richmond, Vanessa and Cohen, Lindsay. Up All Night With New Study Aids. Available at http://www.straight.com/article/up-all-night-with-new-study-aids [accessed 13 June 2011].
- 50.Laurance, Jeremy. 2003. Ritalin abuse hits students looking for an exam kick. Available at: http://www.independent.co.uk/news/education/education-news/ritalin-abuse-hits-students-looking-for--an-exam-kick-537088.html [accessed 13 June 2011].
- 52.Chadwick, Ruth Therapy, Enhancement and Improvement. In: Ruth Chadwick B. Gordijn, R. Chadwick (eds.) Medical Enhancement and Posthumanity. Springer Science & Business Media BV.Google Scholar
- 56.Inciardi, James A., Hilary L. Surratt, Steven P. Kurtz, and Theodore J. Cicero. 2007. Mechanisms of prescription drug diversion among drug-involved club and street-based populations. Pain Medicine 8(2): 171–183.Google Scholar
- 57.Downie, J., S. Outram, and F. Campbell. 2010. Caveat Emptor, Venditor, Et Praescribor: Legal Liability Associated With Methyplenidate Hydrochloride (MPH) Use By Postsecondary Students. Health Law Journal 18: 51–71.Google Scholar
- 58.Forlini, Cynthia and E. Racine. 2009. Autonomy and Coercion in Academic “Cognitive Enhancement” Using Methylphenidate: Perspectives of Key Stakeholders Neuroethics 2:163–177.Google Scholar